nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—kidney cancer	0.127	1	CbGaD
Midazolam—CYP3A7—Temsirolimus—kidney cancer	0.0591	0.096	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0591	0.096	CbGbCtD
Midazolam—CYP3A5—Temsirolimus—kidney cancer	0.0444	0.072	CbGbCtD
Midazolam—ABCB1—Temsirolimus—kidney cancer	0.0289	0.0469	CbGbCtD
Midazolam—CYP3A4—Everolimus—kidney cancer	0.0256	0.0416	CbGbCtD
Midazolam—CYP3A7—Paclitaxel—kidney cancer	0.0203	0.0329	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0203	0.0329	CbGbCtD
Midazolam—CYP3A7—Sorafenib—kidney cancer	0.018	0.0293	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.018	0.0293	CbGbCtD
Midazolam—CYP3A7—Vincristine—kidney cancer	0.0175	0.0284	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0175	0.0284	CbGbCtD
Midazolam—CYP3A4—Temsirolimus—kidney cancer	0.0173	0.0281	CbGbCtD
Midazolam—CYP2B6—Sorafenib—kidney cancer	0.0172	0.0279	CbGbCtD
Midazolam—CYP3A5—Erlotinib—kidney cancer	0.0166	0.027	CbGbCtD
Midazolam—CYP3A5—Paclitaxel—kidney cancer	0.0152	0.0247	CbGbCtD
Midazolam—ABCB1—Pazopanib—kidney cancer	0.0152	0.0246	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0146	0.0237	CbGbCtD
Midazolam—CYP3A7—Sunitinib—kidney cancer	0.0146	0.0237	CbGbCtD
Midazolam—ABCB1—Dactinomycin—kidney cancer	0.0139	0.0225	CbGbCtD
Midazolam—CYP3A5—Sorafenib—kidney cancer	0.0135	0.0219	CbGbCtD
Midazolam—CYP3A5—Vincristine—kidney cancer	0.0131	0.0213	CbGbCtD
Midazolam—ABCB1—Gemcitabine—kidney cancer	0.011	0.0178	CbGbCtD
Midazolam—CYP3A5—Sunitinib—kidney cancer	0.011	0.0178	CbGbCtD
Midazolam—ABCB1—Erlotinib—kidney cancer	0.0108	0.0176	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—kidney cancer	0.0104	0.0169	CbGbCtD
Midazolam—ABCB1—Paclitaxel—kidney cancer	0.0099	0.0161	CbGbCtD
Midazolam—CYP3A4—Pazopanib—kidney cancer	0.00909	0.0147	CbGbCtD
Midazolam—ABCB1—Sorafenib—kidney cancer	0.0088	0.0143	CbGbCtD
Midazolam—ABCB1—Vinblastine—kidney cancer	0.00869	0.0141	CbGbCtD
Midazolam—ABCB1—Vincristine—kidney cancer	0.00854	0.0139	CbGbCtD
Midazolam—ABCB1—Sunitinib—kidney cancer	0.00713	0.0116	CbGbCtD
Midazolam—CYP3A4—Erlotinib—kidney cancer	0.00648	0.0105	CbGbCtD
Midazolam—CYP3A4—Paclitaxel—kidney cancer	0.00593	0.00963	CbGbCtD
Midazolam—ABCB1—Doxorubicin—kidney cancer	0.00534	0.00867	CbGbCtD
Midazolam—CYP3A4—Sorafenib—kidney cancer	0.00527	0.00856	CbGbCtD
Midazolam—CYP3A4—Vinblastine—kidney cancer	0.00521	0.00845	CbGbCtD
Midazolam—CYP3A4—Vincristine—kidney cancer	0.00512	0.00831	CbGbCtD
Midazolam—CYP3A4—Sunitinib—kidney cancer	0.00427	0.00693	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—kidney cancer	0.0032	0.00519	CbGbCtD
Midazolam—UGT1A4—renal system—kidney cancer	0.000819	0.0869	CbGeAlD
Midazolam—UGT1A4—kidney—kidney cancer	0.000792	0.084	CbGeAlD
Midazolam—CYP2E1—urine—kidney cancer	0.000766	0.0812	CbGeAlD
Midazolam—CYP4B1—cardiac atrium—kidney cancer	0.000724	0.0768	CbGeAlD
Midazolam—CYP3A4—urine—kidney cancer	0.000616	0.0653	CbGeAlD
Midazolam—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000534	0.0566	CbGeAlD
Midazolam—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000457	0.0485	CbGeAlD
Midazolam—SLC22A1—renal system—kidney cancer	0.000331	0.0351	CbGeAlD
Midazolam—GABRA2—cortex of kidney—kidney cancer	0.00033	0.035	CbGeAlD
Midazolam—SLC22A1—kidney—kidney cancer	0.00032	0.0339	CbGeAlD
Midazolam—GABRE—cardiac atrium—kidney cancer	0.000311	0.033	CbGeAlD
Midazolam—GABRB3—gonad—kidney cancer	0.000264	0.028	CbGeAlD
Midazolam—CYP3A5—nephron tubule—kidney cancer	0.000221	0.0234	CbGeAlD
Midazolam—CYP2B6—nephron tubule—kidney cancer	0.00022	0.0233	CbGeAlD
Midazolam—Dyspepsia—Sorafenib—kidney cancer	0.000211	0.00122	CcSEcCtD
Midazolam—Visual impairment—Paclitaxel—kidney cancer	0.00021	0.00122	CcSEcCtD
Midazolam—Nausea—Pazopanib—kidney cancer	0.000208	0.00121	CcSEcCtD
Midazolam—Paraesthesia—Sunitinib—kidney cancer	0.000207	0.0012	CcSEcCtD
Midazolam—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000207	0.0012	CcSEcCtD
Midazolam—Fatigue—Sorafenib—kidney cancer	0.000207	0.0012	CcSEcCtD
Midazolam—CYP2E1—nephron tubule—kidney cancer	0.000206	0.0219	CbGeAlD
Midazolam—Dyspnoea—Sunitinib—kidney cancer	0.000206	0.00119	CcSEcCtD
Midazolam—Constipation—Sorafenib—kidney cancer	0.000205	0.00119	CcSEcCtD
Midazolam—Pain—Sorafenib—kidney cancer	0.000205	0.00119	CcSEcCtD
Midazolam—Hypersensitivity—Vinblastine—kidney cancer	0.000204	0.00118	CcSEcCtD
Midazolam—Eye disorder—Paclitaxel—kidney cancer	0.000204	0.00118	CcSEcCtD
Midazolam—Hypersensitivity—Everolimus—kidney cancer	0.000203	0.00118	CcSEcCtD
Midazolam—Dyspepsia—Sunitinib—kidney cancer	0.000203	0.00118	CcSEcCtD
Midazolam—Cardiac disorder—Paclitaxel—kidney cancer	0.000202	0.00117	CcSEcCtD
Midazolam—CYP3A5—renal system—kidney cancer	0.000201	0.0213	CbGeAlD
Midazolam—CYP2B6—renal system—kidney cancer	0.0002	0.0212	CbGeAlD
Midazolam—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000199	0.00116	CcSEcCtD
Midazolam—Asthenia—Vinblastine—kidney cancer	0.000199	0.00115	CcSEcCtD
Midazolam—Fatigue—Sunitinib—kidney cancer	0.000199	0.00115	CcSEcCtD
Midazolam—Depression—Capecitabine—kidney cancer	0.000199	0.00115	CcSEcCtD
Midazolam—Asthenia—Everolimus—kidney cancer	0.000198	0.00115	CcSEcCtD
Midazolam—Cough—Gemcitabine—kidney cancer	0.000198	0.00115	CcSEcCtD
Midazolam—Pain—Sunitinib—kidney cancer	0.000197	0.00114	CcSEcCtD
Midazolam—Constipation—Sunitinib—kidney cancer	0.000197	0.00114	CcSEcCtD
Midazolam—Immune system disorder—Paclitaxel—kidney cancer	0.000197	0.00114	CcSEcCtD
Midazolam—Mediastinal disorder—Paclitaxel—kidney cancer	0.000196	0.00114	CcSEcCtD
Midazolam—Chills—Paclitaxel—kidney cancer	0.000196	0.00114	CcSEcCtD
Midazolam—Neuropathy peripheral—Capecitabine—kidney cancer	0.000195	0.00113	CcSEcCtD
Midazolam—Pruritus—Everolimus—kidney cancer	0.000195	0.00113	CcSEcCtD
Midazolam—Anaphylactic shock—Vincristine—kidney cancer	0.000195	0.00113	CcSEcCtD
Midazolam—CYP3A5—kidney—kidney cancer	0.000194	0.0206	CbGeAlD
Midazolam—Phlebitis—Doxorubicin—kidney cancer	0.000193	0.00112	CcSEcCtD
Midazolam—CYP2B6—kidney—kidney cancer	0.000193	0.0205	CbGeAlD
Midazolam—Thrombophlebitis—Doxorubicin—kidney cancer	0.000193	0.00112	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000192	0.00111	CcSEcCtD
Midazolam—Nervous system disorder—Vincristine—kidney cancer	0.000191	0.00111	CcSEcCtD
Midazolam—Asthenia—Erlotinib—kidney cancer	0.000191	0.00111	CcSEcCtD
Midazolam—Mental disorder—Paclitaxel—kidney cancer	0.000191	0.00111	CcSEcCtD
Midazolam—Urticaria—Sorafenib—kidney cancer	0.00019	0.0011	CcSEcCtD
Midazolam—Erythema—Paclitaxel—kidney cancer	0.00019	0.0011	CcSEcCtD
Midazolam—CYP3A5—cortex of kidney—kidney cancer	0.000189	0.0201	CbGeAlD
Midazolam—Pruritus—Erlotinib—kidney cancer	0.000188	0.00109	CcSEcCtD
Midazolam—Fatigue—Dactinomycin—kidney cancer	0.000188	0.00109	CcSEcCtD
Midazolam—CYP2E1—renal system—kidney cancer	0.000187	0.0199	CbGeAlD
Midazolam—Pain—Dactinomycin—kidney cancer	0.000187	0.00108	CcSEcCtD
Midazolam—Tension—Paclitaxel—kidney cancer	0.000186	0.00108	CcSEcCtD
Midazolam—Anaphylactic shock—Gemcitabine—kidney cancer	0.000185	0.00107	CcSEcCtD
Midazolam—Nervousness—Paclitaxel—kidney cancer	0.000184	0.00107	CcSEcCtD
Midazolam—Dizziness—Vinblastine—kidney cancer	0.000183	0.00106	CcSEcCtD
Midazolam—Dizziness—Everolimus—kidney cancer	0.000183	0.00106	CcSEcCtD
Midazolam—Hypotension—Vincristine—kidney cancer	0.000182	0.00106	CcSEcCtD
Midazolam—Bradycardia—Capecitabine—kidney cancer	0.000182	0.00106	CcSEcCtD
Midazolam—Nervous system disorder—Gemcitabine—kidney cancer	0.000181	0.00105	CcSEcCtD
Midazolam—CYP2E1—kidney—kidney cancer	0.000181	0.0192	CbGeAlD
Midazolam—Feeling abnormal—Dactinomycin—kidney cancer	0.00018	0.00104	CcSEcCtD
Midazolam—Skin disorder—Gemcitabine—kidney cancer	0.00018	0.00104	CcSEcCtD
Midazolam—CYP2B6—gonad—kidney cancer	0.000179	0.019	CbGeAlD
Midazolam—Vision blurred—Paclitaxel—kidney cancer	0.000179	0.00104	CcSEcCtD
Midazolam—Tremor—Paclitaxel—kidney cancer	0.000178	0.00103	CcSEcCtD
Midazolam—Hypersensitivity—Sorafenib—kidney cancer	0.000177	0.00102	CcSEcCtD
Midazolam—CYP2E1—cortex of kidney—kidney cancer	0.000176	0.0187	CbGeAlD
Midazolam—Vomiting—Vinblastine—kidney cancer	0.000176	0.00102	CcSEcCtD
Midazolam—Dizziness—Erlotinib—kidney cancer	0.000176	0.00102	CcSEcCtD
Midazolam—Connective tissue disorder—Capecitabine—kidney cancer	0.000176	0.00102	CcSEcCtD
Midazolam—Vomiting—Everolimus—kidney cancer	0.000175	0.00102	CcSEcCtD
Midazolam—Paraesthesia—Vincristine—kidney cancer	0.000175	0.00102	CcSEcCtD
Midazolam—Agitation—Paclitaxel—kidney cancer	0.000174	0.00101	CcSEcCtD
Midazolam—Rash—Everolimus—kidney cancer	0.000174	0.00101	CcSEcCtD
Midazolam—Dermatitis—Everolimus—kidney cancer	0.000174	0.00101	CcSEcCtD
Midazolam—Headache—Vinblastine—kidney cancer	0.000174	0.00101	CcSEcCtD
Midazolam—Headache—Everolimus—kidney cancer	0.000173	0.001	CcSEcCtD
Midazolam—Hypotension—Gemcitabine—kidney cancer	0.000173	0.001	CcSEcCtD
Midazolam—Visual impairment—Capecitabine—kidney cancer	0.000172	0.001	CcSEcCtD
Midazolam—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000172	0.000999	CcSEcCtD
Midazolam—Asthenia—Sorafenib—kidney cancer	0.000172	0.000998	CcSEcCtD
Midazolam—Cardiac failure—Doxorubicin—kidney cancer	0.000171	0.000991	CcSEcCtD
Midazolam—Vertigo—Paclitaxel—kidney cancer	0.00017	0.000989	CcSEcCtD
Midazolam—Syncope—Paclitaxel—kidney cancer	0.00017	0.000988	CcSEcCtD
Midazolam—Lethargy—Doxorubicin—kidney cancer	0.00017	0.000987	CcSEcCtD
Midazolam—Hypersensitivity—Sunitinib—kidney cancer	0.00017	0.000986	CcSEcCtD
Midazolam—Pruritus—Sorafenib—kidney cancer	0.000169	0.000984	CcSEcCtD
Midazolam—Vomiting—Erlotinib—kidney cancer	0.000169	0.000983	CcSEcCtD
Midazolam—Gastrointestinal disorder—Vincristine—kidney cancer	0.000168	0.000977	CcSEcCtD
Midazolam—Fatigue—Vincristine—kidney cancer	0.000168	0.000976	CcSEcCtD
Midazolam—Rash—Erlotinib—kidney cancer	0.000168	0.000974	CcSEcCtD
Midazolam—Dermatitis—Erlotinib—kidney cancer	0.000168	0.000974	CcSEcCtD
Midazolam—Eye disorder—Capecitabine—kidney cancer	0.000167	0.00097	CcSEcCtD
Midazolam—Headache—Erlotinib—kidney cancer	0.000167	0.000968	CcSEcCtD
Midazolam—Pain—Vincristine—kidney cancer	0.000167	0.000968	CcSEcCtD
Midazolam—Constipation—Vincristine—kidney cancer	0.000167	0.000968	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—kidney cancer	0.000167	0.000967	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—kidney cancer	0.000167	0.000967	CcSEcCtD
Midazolam—Paraesthesia—Gemcitabine—kidney cancer	0.000166	0.000964	CcSEcCtD
Midazolam—Cardiac disorder—Capecitabine—kidney cancer	0.000166	0.000964	CcSEcCtD
Midazolam—Cough—Paclitaxel—kidney cancer	0.000166	0.000961	CcSEcCtD
Midazolam—Asthenia—Sunitinib—kidney cancer	0.000165	0.00096	CcSEcCtD
Midazolam—Dyspnoea—Gemcitabine—kidney cancer	0.000165	0.000957	CcSEcCtD
Midazolam—Nausea—Vinblastine—kidney cancer	0.000165	0.000955	CcSEcCtD
Midazolam—Somnolence—Gemcitabine—kidney cancer	0.000164	0.000954	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—kidney cancer	0.000164	0.000952	CcSEcCtD
Midazolam—Nausea—Everolimus—kidney cancer	0.000164	0.000951	CcSEcCtD
Midazolam—Pruritus—Sunitinib—kidney cancer	0.000163	0.000947	CcSEcCtD
Midazolam—Immune system disorder—Capecitabine—kidney cancer	0.000162	0.000938	CcSEcCtD
Midazolam—Mediastinal disorder—Capecitabine—kidney cancer	0.000161	0.000936	CcSEcCtD
Midazolam—Anxiety—Paclitaxel—kidney cancer	0.000161	0.000934	CcSEcCtD
Midazolam—Hypersensitivity—Dactinomycin—kidney cancer	0.000161	0.000933	CcSEcCtD
Midazolam—Chills—Capecitabine—kidney cancer	0.000161	0.000932	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00016	0.000931	CcSEcCtD
Midazolam—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00016	0.000927	CcSEcCtD
Midazolam—Fatigue—Gemcitabine—kidney cancer	0.000159	0.000926	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—kidney cancer	0.000158	0.00092	CcSEcCtD
Midazolam—Dizziness—Sorafenib—kidney cancer	0.000158	0.000919	CcSEcCtD
Midazolam—Constipation—Gemcitabine—kidney cancer	0.000158	0.000918	CcSEcCtD
Midazolam—Pain—Gemcitabine—kidney cancer	0.000158	0.000918	CcSEcCtD
Midazolam—Nausea—Erlotinib—kidney cancer	0.000158	0.000918	CcSEcCtD
Midazolam—Dry mouth—Paclitaxel—kidney cancer	0.000158	0.000917	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—kidney cancer	0.000158	0.000916	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—kidney cancer	0.000157	0.00091	CcSEcCtD
Midazolam—Mental disorder—Capecitabine—kidney cancer	0.000157	0.00091	CcSEcCtD
Midazolam—Asthenia—Dactinomycin—kidney cancer	0.000157	0.000909	CcSEcCtD
Midazolam—Confusional state—Paclitaxel—kidney cancer	0.000156	0.000906	CcSEcCtD
Midazolam—Erythema—Capecitabine—kidney cancer	0.000156	0.000904	CcSEcCtD
Midazolam—Anaphylactic shock—Paclitaxel—kidney cancer	0.000155	0.000899	CcSEcCtD
Midazolam—Dizziness—Sunitinib—kidney cancer	0.000152	0.000885	CcSEcCtD
Midazolam—Feeling abnormal—Gemcitabine—kidney cancer	0.000152	0.000885	CcSEcCtD
Midazolam—Shock—Paclitaxel—kidney cancer	0.000152	0.000884	CcSEcCtD
Midazolam—Vomiting—Sorafenib—kidney cancer	0.000152	0.000884	CcSEcCtD
Midazolam—Nervous system disorder—Paclitaxel—kidney cancer	0.000152	0.000881	CcSEcCtD
Midazolam—Tachycardia—Paclitaxel—kidney cancer	0.000151	0.000877	CcSEcCtD
Midazolam—Rash—Sorafenib—kidney cancer	0.000151	0.000877	CcSEcCtD
Midazolam—Dermatitis—Sorafenib—kidney cancer	0.000151	0.000876	CcSEcCtD
Midazolam—CYP3A4—renal system—kidney cancer	0.000151	0.016	CbGeAlD
Midazolam—Skin disorder—Paclitaxel—kidney cancer	0.00015	0.000873	CcSEcCtD
Midazolam—Headache—Sorafenib—kidney cancer	0.00015	0.000871	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—kidney cancer	0.000149	0.000865	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—kidney cancer	0.000147	0.000853	CcSEcCtD
Midazolam—Vision blurred—Capecitabine—kidney cancer	0.000147	0.000852	CcSEcCtD
Midazolam—Vomiting—Sunitinib—kidney cancer	0.000147	0.000851	CcSEcCtD
Midazolam—Tremor—Capecitabine—kidney cancer	0.000146	0.000847	CcSEcCtD
Midazolam—CYP3A4—kidney—kidney cancer	0.000146	0.0155	CbGeAlD
Midazolam—Rash—Sunitinib—kidney cancer	0.000145	0.000844	CcSEcCtD
Midazolam—Dermatitis—Sunitinib—kidney cancer	0.000145	0.000843	CcSEcCtD
Midazolam—Hypotension—Paclitaxel—kidney cancer	0.000145	0.00084	CcSEcCtD
Midazolam—Headache—Sunitinib—kidney cancer	0.000144	0.000838	CcSEcCtD
Midazolam—Hypersensitivity—Vincristine—kidney cancer	0.000144	0.000834	CcSEcCtD
Midazolam—Nausea—Sorafenib—kidney cancer	0.000142	0.000826	CcSEcCtD
Midazolam—Vertigo—Capecitabine—kidney cancer	0.00014	0.000812	CcSEcCtD
Midazolam—Asthenia—Vincristine—kidney cancer	0.00014	0.000812	CcSEcCtD
Midazolam—Syncope—Capecitabine—kidney cancer	0.00014	0.00081	CcSEcCtD
Midazolam—Paraesthesia—Paclitaxel—kidney cancer	0.000139	0.000807	CcSEcCtD
Midazolam—Vomiting—Dactinomycin—kidney cancer	0.000139	0.000805	CcSEcCtD
Midazolam—Dyspnoea—Paclitaxel—kidney cancer	0.000138	0.000801	CcSEcCtD
Midazolam—Somnolence—Paclitaxel—kidney cancer	0.000138	0.000799	CcSEcCtD
Midazolam—Rash—Dactinomycin—kidney cancer	0.000138	0.000799	CcSEcCtD
Midazolam—Nausea—Sunitinib—kidney cancer	0.000137	0.000795	CcSEcCtD
Midazolam—Dyspepsia—Paclitaxel—kidney cancer	0.000136	0.000791	CcSEcCtD
Midazolam—Cough—Capecitabine—kidney cancer	0.000136	0.000789	CcSEcCtD
Midazolam—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000134	0.000776	CcSEcCtD
Midazolam—Fatigue—Paclitaxel—kidney cancer	0.000134	0.000775	CcSEcCtD
Midazolam—Asthenia—Gemcitabine—kidney cancer	0.000133	0.00077	CcSEcCtD
Midazolam—Pain—Paclitaxel—kidney cancer	0.000132	0.000769	CcSEcCtD
Midazolam—Constipation—Paclitaxel—kidney cancer	0.000132	0.000769	CcSEcCtD
Midazolam—Anxiety—Capecitabine—kidney cancer	0.000132	0.000767	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000132	0.000764	CcSEcCtD
Midazolam—Pruritus—Gemcitabine—kidney cancer	0.000131	0.00076	CcSEcCtD
Midazolam—Dry mouth—Capecitabine—kidney cancer	0.00013	0.000753	CcSEcCtD
Midazolam—Nausea—Dactinomycin—kidney cancer	0.00013	0.000752	CcSEcCtD
Midazolam—Dizziness—Vincristine—kidney cancer	0.000129	0.000748	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—kidney cancer	0.000128	0.000745	CcSEcCtD
Midazolam—Confusional state—Capecitabine—kidney cancer	0.000128	0.000744	CcSEcCtD
Midazolam—Feeling abnormal—Paclitaxel—kidney cancer	0.000128	0.000741	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000126	0.000731	CcSEcCtD
Midazolam—Shock—Capecitabine—kidney cancer	0.000125	0.000726	CcSEcCtD
Midazolam—Nervous system disorder—Capecitabine—kidney cancer	0.000125	0.000723	CcSEcCtD
Midazolam—Tachycardia—Capecitabine—kidney cancer	0.000124	0.00072	CcSEcCtD
Midazolam—Vomiting—Vincristine—kidney cancer	0.000124	0.00072	CcSEcCtD
Midazolam—Skin disorder—Capecitabine—kidney cancer	0.000123	0.000716	CcSEcCtD
Midazolam—Urticaria—Paclitaxel—kidney cancer	0.000123	0.000714	CcSEcCtD
Midazolam—Rash—Vincristine—kidney cancer	0.000123	0.000714	CcSEcCtD
Midazolam—Dermatitis—Vincristine—kidney cancer	0.000123	0.000713	CcSEcCtD
Midazolam—Headache—Vincristine—kidney cancer	0.000122	0.000709	CcSEcCtD
Midazolam—Hypotension—Capecitabine—kidney cancer	0.000119	0.000689	CcSEcCtD
Midazolam—Vomiting—Gemcitabine—kidney cancer	0.000118	0.000683	CcSEcCtD
Midazolam—ABCB1—nephron tubule—kidney cancer	0.000117	0.0124	CbGeAlD
Midazolam—Bradycardia—Doxorubicin—kidney cancer	0.000117	0.000681	CcSEcCtD
Midazolam—Rash—Gemcitabine—kidney cancer	0.000117	0.000677	CcSEcCtD
Midazolam—Dermatitis—Gemcitabine—kidney cancer	0.000117	0.000676	CcSEcCtD
Midazolam—Headache—Gemcitabine—kidney cancer	0.000116	0.000673	CcSEcCtD
Midazolam—Nausea—Vincristine—kidney cancer	0.000116	0.000672	CcSEcCtD
Midazolam—Paraesthesia—Capecitabine—kidney cancer	0.000114	0.000662	CcSEcCtD
Midazolam—Hypersensitivity—Paclitaxel—kidney cancer	0.000114	0.000662	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—kidney cancer	0.000113	0.000658	CcSEcCtD
Midazolam—Dyspnoea—Capecitabine—kidney cancer	0.000113	0.000658	CcSEcCtD
Midazolam—Dyspepsia—Capecitabine—kidney cancer	0.000112	0.000649	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—kidney cancer	0.000111	0.000645	CcSEcCtD
Midazolam—Asthenia—Paclitaxel—kidney cancer	0.000111	0.000645	CcSEcCtD
Midazolam—Nausea—Gemcitabine—kidney cancer	0.00011	0.000638	CcSEcCtD
Midazolam—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00011	0.000637	CcSEcCtD
Midazolam—Fatigue—Capecitabine—kidney cancer	0.00011	0.000636	CcSEcCtD
Midazolam—Pruritus—Paclitaxel—kidney cancer	0.00011	0.000636	CcSEcCtD
Midazolam—Pain—Capecitabine—kidney cancer	0.000109	0.000631	CcSEcCtD
Midazolam—Constipation—Capecitabine—kidney cancer	0.000109	0.000631	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—kidney cancer	0.000108	0.000625	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—kidney cancer	0.000107	0.000621	CcSEcCtD
Midazolam—ABCB1—renal system—kidney cancer	0.000107	0.0113	CbGeAlD
Midazolam—Feeling abnormal—Capecitabine—kidney cancer	0.000105	0.000608	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—kidney cancer	0.000104	0.000604	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—kidney cancer	0.000104	0.000603	CcSEcCtD
Midazolam—Chills—Doxorubicin—kidney cancer	0.000103	0.0006	CcSEcCtD
Midazolam—ABCB1—kidney—kidney cancer	0.000103	0.0109	CbGeAlD
Midazolam—Dizziness—Paclitaxel—kidney cancer	0.000102	0.000594	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—kidney cancer	0.000101	0.000586	CcSEcCtD
Midazolam—Urticaria—Capecitabine—kidney cancer	0.000101	0.000586	CcSEcCtD
Midazolam—ABCB1—cortex of kidney—kidney cancer	0.0001	0.0107	CbGeAlD
Midazolam—Erythema—Doxorubicin—kidney cancer	0.0001	0.000583	CcSEcCtD
Midazolam—Tension—Doxorubicin—kidney cancer	9.85e-05	0.000572	CcSEcCtD
Midazolam—Vomiting—Paclitaxel—kidney cancer	9.85e-05	0.000571	CcSEcCtD
Midazolam—Rash—Paclitaxel—kidney cancer	9.76e-05	0.000567	CcSEcCtD
Midazolam—Dermatitis—Paclitaxel—kidney cancer	9.76e-05	0.000566	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—kidney cancer	9.75e-05	0.000566	CcSEcCtD
Midazolam—Headache—Paclitaxel—kidney cancer	9.7e-05	0.000563	CcSEcCtD
Midazolam—ABCB1—gonad—kidney cancer	9.57e-05	0.0101	CbGeAlD
Midazolam—Vision blurred—Doxorubicin—kidney cancer	9.46e-05	0.000549	CcSEcCtD
Midazolam—Hypersensitivity—Capecitabine—kidney cancer	9.36e-05	0.000543	CcSEcCtD
Midazolam—Agitation—Doxorubicin—kidney cancer	9.22e-05	0.000535	CcSEcCtD
Midazolam—Nausea—Paclitaxel—kidney cancer	9.2e-05	0.000534	CcSEcCtD
Midazolam—Asthenia—Capecitabine—kidney cancer	9.12e-05	0.000529	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—kidney cancer	9.02e-05	0.000523	CcSEcCtD
Midazolam—Syncope—Doxorubicin—kidney cancer	9e-05	0.000522	CcSEcCtD
Midazolam—Pruritus—Capecitabine—kidney cancer	8.99e-05	0.000522	CcSEcCtD
Midazolam—Cough—Doxorubicin—kidney cancer	8.76e-05	0.000508	CcSEcCtD
Midazolam—Anxiety—Doxorubicin—kidney cancer	8.52e-05	0.000494	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	8.49e-05	0.000493	CcSEcCtD
Midazolam—Dizziness—Capecitabine—kidney cancer	8.4e-05	0.000488	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—kidney cancer	8.36e-05	0.000485	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—kidney cancer	8.26e-05	0.000479	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—kidney cancer	8.19e-05	0.000475	CcSEcCtD
Midazolam—Vomiting—Capecitabine—kidney cancer	8.08e-05	0.000469	CcSEcCtD
Midazolam—Shock—Doxorubicin—kidney cancer	8.06e-05	0.000468	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—kidney cancer	8.03e-05	0.000466	CcSEcCtD
Midazolam—Rash—Capecitabine—kidney cancer	8.01e-05	0.000465	CcSEcCtD
Midazolam—Dermatitis—Capecitabine—kidney cancer	8.01e-05	0.000465	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—kidney cancer	8e-05	0.000464	CcSEcCtD
Midazolam—Headache—Capecitabine—kidney cancer	7.96e-05	0.000462	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—kidney cancer	7.96e-05	0.000462	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—kidney cancer	7.65e-05	0.000444	CcSEcCtD
Midazolam—Nausea—Capecitabine—kidney cancer	7.55e-05	0.000438	CcSEcCtD
Midazolam—Paraesthesia—Doxorubicin—kidney cancer	7.36e-05	0.000427	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—kidney cancer	7.3e-05	0.000424	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—kidney cancer	7.28e-05	0.000423	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—kidney cancer	7.21e-05	0.000419	CcSEcCtD
Midazolam—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.07e-05	0.00041	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—kidney cancer	7.06e-05	0.00041	CcSEcCtD
Midazolam—Pain—Doxorubicin—kidney cancer	7.01e-05	0.000407	CcSEcCtD
Midazolam—Constipation—Doxorubicin—kidney cancer	7.01e-05	0.000407	CcSEcCtD
Midazolam—Feeling abnormal—Doxorubicin—kidney cancer	6.75e-05	0.000392	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—kidney cancer	6.51e-05	0.000378	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—kidney cancer	6.04e-05	0.00035	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—kidney cancer	5.88e-05	0.000341	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—kidney cancer	5.8e-05	0.000336	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—kidney cancer	5.42e-05	0.000314	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—kidney cancer	5.21e-05	0.000302	CcSEcCtD
Midazolam—Rash—Doxorubicin—kidney cancer	5.17e-05	0.0003	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—kidney cancer	5.16e-05	0.0003	CcSEcCtD
Midazolam—Headache—Doxorubicin—kidney cancer	5.13e-05	0.000298	CcSEcCtD
Midazolam—Nausea—Doxorubicin—kidney cancer	4.87e-05	0.000282	CcSEcCtD
Midazolam—CYP2E1—Metabolism—APRT—kidney cancer	1.98e-05	0.000262	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—FH—kidney cancer	1.98e-05	0.000262	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APRT—kidney cancer	1.98e-05	0.000262	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—FH—kidney cancer	1.98e-05	0.000262	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PDHB—kidney cancer	1.97e-05	0.00026	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.96e-05	0.000259	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSTP1—kidney cancer	1.96e-05	0.000259	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GPC3—kidney cancer	1.9e-05	0.000252	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.9e-05	0.000251	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CA9—kidney cancer	1.9e-05	0.000251	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—MAPK1—kidney cancer	1.88e-05	0.000249	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—RAF1—kidney cancer	1.88e-05	0.000248	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GPC3—kidney cancer	1.86e-05	0.000246	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.86e-05	0.000246	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GPC3—kidney cancer	1.86e-05	0.000246	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ABCB1—kidney cancer	1.86e-05	0.000246	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CCBL1—kidney cancer	1.85e-05	0.000245	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CA2—kidney cancer	1.85e-05	0.000245	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.84e-05	0.000243	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—MAPK1—kidney cancer	1.83e-05	0.000242	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CA2—kidney cancer	1.81e-05	0.00024	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CA2—kidney cancer	1.81e-05	0.000239	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALAD—kidney cancer	1.8e-05	0.000238	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSTM1—kidney cancer	1.8e-05	0.000238	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—MAPK1—kidney cancer	1.79e-05	0.000237	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.78e-05	0.000236	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALAD—kidney cancer	1.77e-05	0.000234	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CA9—kidney cancer	1.77e-05	0.000233	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALAD—kidney cancer	1.76e-05	0.000233	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—MAPK1—kidney cancer	1.76e-05	0.000233	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ST3GAL2—kidney cancer	1.76e-05	0.000233	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—MAPK1—kidney cancer	1.75e-05	0.000232	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.75e-05	0.000232	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.73e-05	0.000228	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ST3GAL2—kidney cancer	1.73e-05	0.000228	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ST3GAL2—kidney cancer	1.72e-05	0.000228	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALDH1A1—kidney cancer	1.72e-05	0.000228	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—MAPK1—kidney cancer	1.72e-05	0.000227	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.71e-05	0.000226	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP1A1—kidney cancer	1.71e-05	0.000226	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.69e-05	0.000223	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALDH1A1—kidney cancer	1.69e-05	0.000223	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.68e-05	0.000222	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.68e-05	0.000222	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC5A3—kidney cancer	1.65e-05	0.000218	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PGK1—kidney cancer	1.65e-05	0.000218	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.63e-05	0.000216	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTGS2—kidney cancer	1.63e-05	0.000215	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.62e-05	0.000215	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—LDHB—kidney cancer	1.62e-05	0.000214	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PGK1—kidney cancer	1.62e-05	0.000214	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC5A3—kidney cancer	1.62e-05	0.000214	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CRABP1—kidney cancer	1.61e-05	0.000213	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PGK1—kidney cancer	1.61e-05	0.000213	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.61e-05	0.000213	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	1.61e-05	0.000213	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GLIPR1—kidney cancer	1.61e-05	0.000212	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPAT—kidney cancer	1.61e-05	0.000212	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.6e-05	0.000212	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—LDHB—kidney cancer	1.59e-05	0.00021	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—LDHB—kidney cancer	1.58e-05	0.000209	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—MAPK1—kidney cancer	1.5e-05	0.000199	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CRABP1—kidney cancer	1.5e-05	0.000198	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ITPR2—kidney cancer	1.5e-05	0.000198	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—FH—kidney cancer	1.49e-05	0.000197	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APRT—kidney cancer	1.49e-05	0.000197	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.49e-05	0.000197	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.47e-05	0.000195	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.47e-05	0.000195	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.44e-05	0.00019	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.43e-05	0.000189	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ACY1—kidney cancer	1.43e-05	0.000189	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTEN—kidney cancer	1.42e-05	0.000187	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.41e-05	0.000186	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GPC3—kidney cancer	1.4e-05	0.000186	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CA9—kidney cancer	1.4e-05	0.000185	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ITPR2—kidney cancer	1.4e-05	0.000184	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.38e-05	0.000183	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CA9—kidney cancer	1.37e-05	0.000182	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.37e-05	0.000182	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CA9—kidney cancer	1.37e-05	0.000181	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.37e-05	0.000181	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ACHE—kidney cancer	1.37e-05	0.000181	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTT1—kidney cancer	1.37e-05	0.000181	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CA2—kidney cancer	1.37e-05	0.000181	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.36e-05	0.00018	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.35e-05	0.000178	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALAD—kidney cancer	1.33e-05	0.000176	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.32e-05	0.000175	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.3e-05	0.000172	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.3e-05	0.000172	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.3e-05	0.000172	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SCARB1—kidney cancer	1.29e-05	0.000171	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.29e-05	0.00017	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—MAPK1—kidney cancer	1.29e-05	0.00017	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS1—kidney cancer	1.28e-05	0.000169	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—POMC—kidney cancer	1.27e-05	0.000168	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTT1—kidney cancer	1.27e-05	0.000168	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ACHE—kidney cancer	1.27e-05	0.000168	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.27e-05	0.000168	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PSMD7—kidney cancer	1.26e-05	0.000166	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.26e-05	0.000166	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PGK1—kidney cancer	1.22e-05	0.000161	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC5A3—kidney cancer	1.22e-05	0.000161	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PDHB—kidney cancer	1.21e-05	0.00016	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—POMC—kidney cancer	1.21e-05	0.00016	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SCARB1—kidney cancer	1.2e-05	0.000159	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—LDHB—kidney cancer	1.19e-05	0.000158	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CRABP1—kidney cancer	1.19e-05	0.000158	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS1—kidney cancer	1.19e-05	0.000158	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—BCHE—kidney cancer	1.19e-05	0.000157	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.18e-05	0.000156	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.18e-05	0.000156	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PSMD7—kidney cancer	1.17e-05	0.000155	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CRABP1—kidney cancer	1.17e-05	0.000154	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CRABP1—kidney cancer	1.17e-05	0.000154	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CCBL1—kidney cancer	1.14e-05	0.000151	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.14e-05	0.00015	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.13e-05	0.00015	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ITPR2—kidney cancer	1.11e-05	0.000147	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—BCHE—kidney cancer	1.11e-05	0.000147	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SLC5A5—kidney cancer	1.1e-05	0.000145	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ITPR2—kidney cancer	1.09e-05	0.000144	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ITPR2—kidney cancer	1.08e-05	0.000143	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.07e-05	0.000142	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SLC2A1—kidney cancer	1.06e-05	0.00014	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.04e-05	0.000138	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CA9—kidney cancer	1.04e-05	0.000137	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.02e-05	0.000135	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTGS2—kidney cancer	1.02e-05	0.000134	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ACHE—kidney cancer	1.01e-05	0.000134	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTT1—kidney cancer	1.01e-05	0.000134	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.01e-05	0.000133	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CA—kidney cancer	1e-05	0.000132	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ACHE—kidney cancer	9.91e-06	0.000131	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTT1—kidney cancer	9.91e-06	0.000131	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GLIPR1—kidney cancer	9.9e-06	0.000131	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPAT—kidney cancer	9.9e-06	0.000131	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTT1—kidney cancer	9.89e-06	0.000131	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ACHE—kidney cancer	9.89e-06	0.000131	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	9.65e-06	0.000128	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SCARB1—kidney cancer	9.58e-06	0.000127	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTP1—kidney cancer	9.48e-06	0.000125	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS1—kidney cancer	9.48e-06	0.000125	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SCARB1—kidney cancer	9.38e-06	0.000124	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SCARB1—kidney cancer	9.36e-06	0.000124	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PSMD7—kidney cancer	9.3e-06	0.000123	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS1—kidney cancer	9.28e-06	0.000123	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS1—kidney cancer	9.27e-06	0.000122	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APRT—kidney cancer	9.2e-06	0.000122	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FH—kidney cancer	9.2e-06	0.000122	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PSMD7—kidney cancer	9.1e-06	0.00012	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PSMD7—kidney cancer	9.09e-06	0.00012	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ABCB1—kidney cancer	8.97e-06	0.000119	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTEN—kidney cancer	8.87e-06	0.000117	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	8.86e-06	0.000117	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTP1—kidney cancer	8.82e-06	0.000117	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—BCHE—kidney cancer	8.81e-06	0.000116	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CRABP1—kidney cancer	8.8e-06	0.000116	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTM1—kidney cancer	8.71e-06	0.000115	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC5A5—kidney cancer	8.7e-06	0.000115	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPC3—kidney cancer	8.65e-06	0.000114	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—BCHE—kidney cancer	8.63e-06	0.000114	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—BCHE—kidney cancer	8.61e-06	0.000114	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.57e-06	0.000113	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC5A5—kidney cancer	8.53e-06	0.000113	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC5A5—kidney cancer	8.51e-06	0.000112	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CA2—kidney cancer	8.41e-06	0.000111	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC2A1—kidney cancer	8.41e-06	0.000111	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ABCB1—kidney cancer	8.35e-06	0.00011	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1A1—kidney cancer	8.26e-06	0.000109	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC2A1—kidney cancer	8.23e-06	0.000109	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC2A1—kidney cancer	8.22e-06	0.000109	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALAD—kidney cancer	8.2e-06	0.000108	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ITPR2—kidney cancer	8.18e-06	0.000108	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTM1—kidney cancer	8.11e-06	0.000107	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8e-06	0.000106	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.82e-06	0.000103	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1A1—kidney cancer	7.69e-06	0.000102	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.5e-06	9.91e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PGK1—kidney cancer	7.5e-06	9.91e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ACHE—kidney cancer	7.46e-06	9.86e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTT1—kidney cancer	7.46e-06	9.86e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LDHB—kidney cancer	7.35e-06	9.72e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SCARB1—kidney cancer	7.06e-06	9.33e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTP1—kidney cancer	7.01e-06	9.27e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS1—kidney cancer	6.99e-06	9.24e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTP1—kidney cancer	6.87e-06	9.08e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PSMD7—kidney cancer	6.86e-06	9.06e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTP1—kidney cancer	6.85e-06	9.06e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ABCB1—kidney cancer	6.64e-06	8.77e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ABCB1—kidney cancer	6.5e-06	8.59e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BCHE—kidney cancer	6.5e-06	8.59e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ABCB1—kidney cancer	6.49e-06	8.57e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTM1—kidney cancer	6.44e-06	8.52e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC5A5—kidney cancer	6.42e-06	8.49e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CA9—kidney cancer	6.38e-06	8.43e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTM1—kidney cancer	6.31e-06	8.34e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTM1—kidney cancer	6.3e-06	8.32e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—kidney cancer	6.26e-06	8.27e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC2A1—kidney cancer	6.2e-06	8.2e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—POMC—kidney cancer	6.16e-06	8.14e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1A1—kidney cancer	6.11e-06	8.07e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1A1—kidney cancer	5.98e-06	7.91e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1A1—kidney cancer	5.97e-06	7.89e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.91e-06	7.82e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—POMC—kidney cancer	5.73e-06	7.57e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CRABP1—kidney cancer	5.42e-06	7.17e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTP1—kidney cancer	5.17e-06	6.84e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ITPR2—kidney cancer	5.04e-06	6.66e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—kidney cancer	4.91e-06	6.49e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTM1—kidney cancer	4.75e-06	6.28e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ACHE—kidney cancer	4.6e-06	6.08e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTT1—kidney cancer	4.6e-06	6.08e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—kidney cancer	4.57e-06	6.04e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—POMC—kidney cancer	4.55e-06	6.02e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1A1—kidney cancer	4.51e-06	5.95e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—POMC—kidney cancer	4.46e-06	5.9e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—POMC—kidney cancer	4.45e-06	5.88e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SCARB1—kidney cancer	4.35e-06	5.75e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS1—kidney cancer	4.31e-06	5.69e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTEN—kidney cancer	4.28e-06	5.66e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PSMD7—kidney cancer	4.22e-06	5.58e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BCHE—kidney cancer	4e-06	5.29e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTEN—kidney cancer	3.99e-06	5.27e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.96e-06	5.23e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.82e-06	5.05e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—kidney cancer	3.63e-06	4.8e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—kidney cancer	3.56e-06	4.7e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—kidney cancer	3.55e-06	4.69e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—POMC—kidney cancer	3.36e-06	4.44e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTP1—kidney cancer	3.19e-06	4.21e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTEN—kidney cancer	3.17e-06	4.19e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTEN—kidney cancer	3.1e-06	4.1e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTEN—kidney cancer	3.1e-06	4.09e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—kidney cancer	3.02e-06	3.99e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCB1—kidney cancer	3.02e-06	3.99e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM1—kidney cancer	2.93e-06	3.87e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—kidney cancer	2.81e-06	3.72e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.78e-06	3.67e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—kidney cancer	2.68e-06	3.54e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTEN—kidney cancer	2.34e-06	3.09e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—kidney cancer	2.23e-06	2.95e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—kidney cancer	2.19e-06	2.89e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.18e-06	2.89e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—POMC—kidney cancer	2.07e-06	2.74e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—kidney cancer	1.65e-06	2.18e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—kidney cancer	1.65e-06	2.18e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTEN—kidney cancer	1.44e-06	1.9e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.02e-06	1.34e-05	CbGpPWpGaD
